Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03335150 · ClinicalTrials.gov registry record · NA

Cognitive Rehabilitation for PD

A NA study of Parkinson's Disease, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT03335150: Completed NA study of Parkinson's Disease, sponsored by VA Office of Research and Development.

NCT03335150 is a NA study of Parkinson's Disease that has completed, run by VA Office of Research and Development. The registered enrollment target is 110 participants, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03335150, a NA study of Parkinson's Disease, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

To investigate the effectiveness of a novel compensatory cognitive rehabilitation program for individuals with Parkinson's disease (PD) and mild cognitive impairment (MCI).

Primary Outcome

The WAIS-IV Matrix Reasoning test is a validated, objective measure of executive function. Scaled scores range from 0 to 26. Higher scores indicate better executive function. Scores reported below are change scores.

Conditions Studied

Parkinson's Disease

Interventions

  • BEHAVIORAL Supportive Care
  • BEHAVIORAL CogSMART-PD

Study Locations (1)

California

  • VA San Diego Healthcare System, San Diego, CA - San Diego

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2015-11-02
Est. Completion 2021-01-31
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT03335150 record still lists

NCT03335150 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 2 interventions - of which Supportive Care is the first listed.

NCT03335150 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03335150 about?

NCT03335150 is a clinical study titled "Cognitive Rehabilitation for PD". To investigate the effectiveness of a novel compensatory cognitive rehabilitation program for individuals with Parkinson's disease (PD) and mild cognitive impairment (MCI).

What is the current status of trial NCT03335150?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2015-11-02. Estimated completion is 2021-01-31.

What conditions does trial NCT03335150 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT03335150?

The interventions under investigation include: Supportive Care (BEHAVIORAL), CogSMART-PD (BEHAVIORAL).

Who is sponsoring clinical trial NCT03335150?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03335150 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03335150's enrollment target sits among peer trials

110 51st of 158 higher than 107 of 158 other Parkinson's Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03335150, the US trial registry maintained by the National Library of Medicine. NCT03335150 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.